Back to CHRS Stock Lookup

Coherus BioSciences (CHRS) – StreetInsider.com Reports

Nov 25, 2016 10:06 AM Standpoint Research Starts Coherus Biosciences (CHRS) at Buy
Nov 9, 2016 04:04 PM Coherus BioSciences (CHRS) Reports Q3 EPS of $1.67
Nov 7, 2016 01:20 PM Coherus BioSciences (CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg
Nov 7, 2016 12:53 PM Unusual 11 Mid-Day Movers 11/7: (NILE) (MFIN) (IONS) Higher; (CXRX) (CHRS) (HLTH) Lower
Nov 7, 2016 12:40 PM Coherus BioSciences (CHRS) Receives Adverse PTAB Decision Over HUMIRA IPR
Nov 7, 2016 12:13 PM AbbVie (ABBV) said to win its case against Coherus (CHRS)
Nov 7, 2016 12:11 PM AbbVie (ABBV) Surges Higher
Nov 7, 2016 12:11 PM Coherus BioSciences (CHRS) halted on LUDP after plunging 10% mid-day
Oct 18, 2016 04:05 PM Baird Starts Coherus Biosciences (CHRS) at Outperform
Oct 7, 2016 05:58 AM Coherus BioSciences' (CHRS) Neulasta BLA Accepted by U.S. FDA
Oct 6, 2016 04:12 PM Coherus BioSciences (CHRS) Completes Two Enbrel PK Studies
Sep 27, 2016 08:02 AM Coherus BioSciences (CHRS) Regains All CHS-0214 Development and Commercial Rights from Shire (SHPG)
Sep 6, 2016 05:07 PM Maxim Group Starts Coherus Biosciences (CHRS) at Buy
Aug 9, 2016 04:20 PM Coherus BioSciences (CHRS) Reports Q4 Loss of $1.72/Share
Aug 9, 2016 01:55 PM Coherus BioSciences (CHRS) Announces Submission of CHS-1701 BLA to U.S. FDA Under 351(k) Pathway
Aug 8, 2016 08:38 AM Coherus BioSciences (CHRS) Announces CHS-1420 Phase 3 Met Primary Endpoint
Jul 27, 2016 10:45 AM Notable Analyst Rating Changes 7/27: (CHK) (AXTA) (SPWR) Upgraded; (TERP) (CLGX) (DEPO) Downgraded
Jul 27, 2016 07:51 AM Citi Starts Coherus Biosciences (CHRS) at Buy
Jul 11, 2016 01:02 PM Unusual 11 Mid-Day Movers 7/11: (BLFS) (SGNT) (REN) Higher; (VII) (BGI) (CLWT) Lower
Jul 11, 2016 08:32 AM Coherus BioSciences (CHRS) CHS-1701 Follow-on Study Met All co-Primary Endpoints
Jun 29, 2016 07:56 AM Credit Suisse Sees $157B of FCF Through 2019 Available for M&A in Biotech/Pharma Sector
Jun 13, 2016 02:05 PM Coherus BioSciences (CHRS) Announces Favorable PTAB Decision for IPR Petitions (ABBV)
Jun 13, 2016 01:22 PM Coherus BioSciences' (CHRS) IPR Said Instituted Against AbbVie's (ABBV) '680, '987 Humira Patents
Jun 10, 2016 12:06 PM Coherus BioSciences (CHRS) Announces Results of Study Demonstrating CHS-0214 Equivalence to Enbrel
May 26, 2016 03:30 PM Coherus BioSciences (CHRS) Issued Three U.S. Patents Related to CHS-1420
May 23, 2016 01:01 PM Unusual 11 Mid-Day Movers 5/23: (XNPT) (REXI) (COVS) Higher; (KLXI) (TPUB) (CSTE) Lower
May 23, 2016 09:20 AM Coherus BioSciences (CHRS) Prices 3.5M Stock Offering at $18/Share
May 23, 2016 06:14 AM Coherus BioSciences (CHRS) Plans 3.5M Common Stock Offering
May 17, 2016 03:12 PM Abbvie's (ABBV) 'Hold' Rating Maintained at Deutsche Bank as Coherus (CHRS) Takes Aim at '135 Patent
May 17, 2016 12:54 PM Unusual 11 Mid-Day Movers 5/17: (MGT) (TISA) (CYTX) Higher; (FRAN) (AEGR) (VSR) Lower
May 17, 2016 12:24 PM BMO Capital Weighs in on Abbvie (ABBV) Amid IPR Decision
May 17, 2016 10:36 AM Coherus BioSciences (CHRS) Receives Favorable PTAB Decision in ‘135 IPR (ABBV)
May 17, 2016 10:07 AM UPDATE: AbbVie (ABBV) Declines 5%, Coherus BioSciences (CHRS) Halted as Humira Patent to Be Reviewed
May 17, 2016 10:00 AM Coherus BioSciences (CHRS) Halted, News Pending
May 17, 2016 07:31 AM Wall Street sells off amid Fed rate hike jitters
Mar 31, 2016 02:41 PM FDA Guidance Covering Labeling for Biosimilar Products Seen as Positive for Biosimilar Manufacturers, Says Mizuho Securities (PFNX) (CHRS) (EPRS)
Feb 29, 2016 09:46 AM Coherus BioSciences (CHRS) Enters $100M Conv. Notes Private Placement
Feb 1, 2016 04:13 PM Coherus BioSciences (CHRS) Annoucnes CHS-1701 Immunogenicity Study Met All Endpoints
Jan 20, 2016 09:01 AM Credit Suisse Launches Biotech Coverage: Gilead (GILD), Amgen (AMGN), Celgene (CELG) Garner Outpeform Rating; Biogen (BIIB) at Neutral
Jan 20, 2016 06:47 AM Credit Suisse Starts Coherus Biosciences (CHRS) at Outperform, $25 PT
Jan 11, 2016 06:48 AM Coherus BioSciences (CHRS), Baxalta (BXLT) Announce CHS-0214 Phase 3 Met Primary Endpoint in RA
Dec 21, 2015 09:41 AM Coherus BioSciences (CHRS) Files $400M Mixed Shelf; 390k Common Shelf for Shareholders
Dec 21, 2015 09:32 AM Coherus BioSciences (CHRS) Announces Manufacturing Agreement for CHS-1701
Dec 14, 2015 04:45 PM Coherus BioSciences (CHRS) Receives $35M Milestone from Baxalta (BXLT)
Dec 9, 2015 09:32 AM Pre-Open Stock Movers 12/09: (VRA) (SUNE) (CARA) Higher; (AEZS) (ONTY) (SIGM) Lower (more...)
Dec 8, 2015 06:09 PM After Hours Stock Movers 12/08: (SBLK) (WYNN) (AVAV) Higher; (ONTY) (AEZS) (KMR) Lower (more...)
Dec 8, 2015 04:01 PM Coherus BioSciences (CHRS) Plans Follow-on Study for CHS-1701 Program
Nov 23, 2015 06:37 AM Barclays Starts Coherus Biosciences (CHRS) at Overweight
Nov 9, 2015 04:43 PM Coherus BioSciences (CHRS) Reports Q3 Loss Per Share of $1.86
Nov 9, 2015 04:41 PM Coherus Bio (CHRS), Baxalta (BXLT) Announced CHS-0214 Met Primary Efficacy Endpoints in Phase 3 Psoriasis Study

Back to CHRS Stock Lookup